These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 426187)

  • 1. The variability of estrogen receptors in metastatic breast cancer.
    Brennan MJ; Donegan WL; Appleby DE
    Am J Surg; 1979 Feb; 137(2):260-2. PubMed ID: 426187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptors and breast cancer: prognostic and therapeutic implications.
    Gapinski PV; Donegan WL
    Surgery; 1980 Sep; 88(3):386-93. PubMed ID: 7414516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between estrogen receptor values and clinical data in predicting the response to endocrine therapy for patients with advanced breast cancer.
    Byar DP; Sears ME; McGuire WL
    Eur J Cancer (1965); 1979 Mar; 15(3):299-310. PubMed ID: 446512
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical predictive criteria for response to endocrine treatment and the receptor status.
    Maass H; Jonat W
    Recent Results Cancer Res; 1980; 71():26-9. PubMed ID: 7378140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer.
    Kiang DT; Frenning DH; Goldman AI; Ascensao VF; Kennedy BJ
    N Engl J Med; 1978 Dec; 299(24):1330-4. PubMed ID: 714108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prediction of hormonal dependency of mammary cancer.
    Block GE; Jensen EV; Polley TZ
    Ann Surg; 1975 Sep; 182(3):342-52. PubMed ID: 169754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of estrogen receptors in predicting hormonal responsiveness in treatment of metastatic breast cancer.
    Valenstein SL; Voigt W; Vogel CL; Thomsen S; Temple W
    J Fla Med Assoc; 1979 Nov; 66(11):1144-8. PubMed ID: 501325
    [No Abstract]   [Full Text] [Related]  

  • 8. Estrogen receptor in breast cancer of the Japanese.
    Nomura Y
    Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results and merit of estrogen receptor data derived from metastatic tumors of the breast.
    Jochimsen PR; Ness SJ; Sherman BM
    Surg Gynecol Obstet; 1978 Dec; 147(6):842-4. PubMed ID: 715657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of multiple steroid receptor assays in breast cancer management.
    Skinner LG; Barnes DM; Ribeiro GG
    Cancer; 1980 Dec; 46(12 Suppl):2939-45. PubMed ID: 7448741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical applications of receptor measurements in breast cancer.
    Holdaway IM; Mountjoy KG; Harvey VJ; Allen EP; Stephens EJ
    Br J Cancer; 1980 Jan; 41(1):136-9. PubMed ID: 7362774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancer.
    Wang G; Vogel CL; Hilsenbeck SG; Voigt W; Thomsen S
    Breast Cancer Res Treat; 1984; 4(4):283-8. PubMed ID: 6518294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations of the receptor content and ultrastructure of breast cancer cells.
    Tulusan AH; Hamann M; Prestele H; Ramming I; von Maillot K; Egger H
    Arch Gynecol; 1982; 231(3):177-84. PubMed ID: 7125699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selection of patients with breast cancer with regard to endocrine therapy].
    Cikes M; Pettavel J
    Schweiz Med Wochenschr; 1977 Nov; 107(46):1645-55. PubMed ID: 199940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer.
    Paridaens R; Sylvester RJ; Ferrazzi E; Legros N; Leclercq G; Heuson JC
    Cancer; 1980 Dec; 46(12 Suppl):2889-95. PubMed ID: 7448734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor status: an important variable in predicting response to endocrine therapy in metastatic breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC; Warren R
    Eur J Cancer (1965); 1980 Mar; 16(3):323-31. PubMed ID: 7371687
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative oestradiol receptor values in primary breast cancer and response of metastases to endocrine therapy.
    Campbell FC; Blamey RW; Elston CW; Morris AH; Nicholson RI; Griffiths K; Haybittle JL
    Lancet; 1981 Dec; 2(8259):1317-9. PubMed ID: 6118718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of progesterone receptor assays in the management of advanced breast cancer.
    Degenshein GA; Bloom N; Tobin E
    Cancer; 1980 Dec; 46(12 Suppl):2789-93. PubMed ID: 7448722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in receptor status between primary and metastatic breast cancer.
    Holdaway IM; Bowditch JV
    Cancer; 1983 Aug; 52(3):479-85. PubMed ID: 6861087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.